You are investing in a healthier future, and semaglutide is the tool that can help you get there
We have dedicated support staff available for appointments to talk through any questions or concerns you have
Taking two doses too close together increases your risk of nausea, vomiting, and gastrointestinal distress
The aim of this retrospective study was to describe and characterize the dermoscopic patterns exhibited by LMM
In PsA, the phase 3b TOGETHER-PsA trial (NCT06588296) assesses the combined use of ixekizumab and tirzepatide in patients with active disease and concomitant overweight or obesity, while the phase 4 TOGETHER AMPLIFY-PsA study (NCT06864026) examines the effectiveness of adding tirzepatide to ixekizumab in clinical practice over 12 months
There were some misleading news articles in Spring, 2025, that likely misinterpreted some reported data to say that GLP-1 drugs for obesity would be cost saving